Therapeutic probiotics and prebiotics are emerging as powerful tools in the treatment and management of various health conditions. Probiotics, with their ability to restore balance in the gut microbiome, have shown effectiveness in managing gastrointestinal disorders like irritable bowel syndrome, ulcerative colitis, and Crohn’s disease. These beneficial microorganisms help reduce inflammation, enhance gut barrier function, and modulate immune responses. Prebiotics, on the other hand, serve as a food source for beneficial bacteria, promoting their growth and activity. Together, therapeutic probiotics and prebiotics offer synergistic effects in managing conditions such as obesity, diabetes, and even mental health disorders like anxiety and depression. The growing body of research continues to expand their therapeutic potential, making them integral components of personalized medicine.
Title : Probiotics in the prevention and treatment of atherosclerotic cardiovascular disease: Focus on molecular mechanisms
Dipak P Ramji, Cardiff University, United Kingdom
Title : Effect of dietary probiotic on the pH and colour characteristics of carcasses, breast fillets and drumsticks of broilers
Nurinisa Esenbuga, Ataturk University, Turkey
Title : Phytochemical analysis and antioxidant activity of Physalis minima
Suriyavathana Muthukrishnan, Periyar University, India
Title : Scale up for manufacturing next generation probiotics: Process development strategies and processes to fast track products into the market
Jason Ryan, Sacco System, Australia
Title : Bacillus subtilis natto: A next-generation probiotic with positive implications in immunological, metabolic, and neurological health
Roberto Ricardo Grau, National University of Rosario, Argentina
Title : Canned cherries made with lactitol or xilitol: A dietetics and prebiotic alternative to reduce its caloric value
Mariela Maldonado, CONICET-UTN FRM, Argentina